Ait-Ahmed Y, Lafdil F
Liver Res. 2025; 7(1):26-34.
PMID: 39959704
PMC: 11791919.
DOI: 10.1016/j.livres.2023.01.001.
Tripathi S, Sharma Y, Kumar D
Metabol Open. 2025; 25:100347.
PMID: 39876904
PMC: 11772974.
DOI: 10.1016/j.metop.2025.100347.
Gan X, Dai G, Li Y, Xu L, Liu G
Cancer Biol Med. 2024; 21(10).
PMID: 39475214
PMC: 11523274.
DOI: 10.20892/j.issn.2095-3941.2024.0224.
Monemi M, Garrosi L, Mirzaei S, Farhadi B, Disfani R, Zabihi M
Ann Med Surg (Lond). 2024; 86(10):5784-5792.
PMID: 39359748
PMC: 11444621.
DOI: 10.1097/MS9.0000000000002513.
Elabd N, Helal M, Elkhayat M, Abd-ElKhalek H, Ahmed D, El-Shemy A
Can J Infect Dis Med Microbiol. 2024; 2024:5797895.
PMID: 39071840
PMC: 11281855.
DOI: 10.1155/2024/5797895.
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases.
Wang M, Zhang H, Chen F, Guo X, Liu Q, Hou J
Exp Hematol Oncol. 2024; 13(1):62.
PMID: 38890694
PMC: 11184755.
DOI: 10.1186/s40164-024-00527-1.
Human umbilical cord mesenchymal stem cells promoted tumor cell growth associated with increased interleukin-18 in hepatocellular carcinoma.
Yang Y, Li S, Peng Q, Guo Y, Gao Y, Gong Y
Mol Biol Rep. 2024; 51(1):762.
PMID: 38874690
DOI: 10.1007/s11033-024-09688-y.
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets.
Pessino G, Scotti C, Maggi M, Immuno-Hub Consortium
Cancers (Basel). 2024; 16(5).
PMID: 38473265
PMC: 10931414.
DOI: 10.3390/cancers16050901.
Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies.
Park E, Lee C
Exp Mol Med. 2024; 56(1):100-109.
PMID: 38182653
PMC: 10834419.
DOI: 10.1038/s12276-023-01150-6.
Exerkines and osteoarthritis.
Jia S, Yu Z, Bai L
Front Physiol. 2023; 14:1302769.
PMID: 38107476
PMC: 10722202.
DOI: 10.3389/fphys.2023.1302769.
Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View.
Nenu I, Toadere T, Topor I, tichindeleanu A, Bondor D, Trella S
Biomedicines. 2023; 11(10).
PMID: 37892997
PMC: 10603956.
DOI: 10.3390/biomedicines11102623.
and study: Ethanolic extract leaves of Juss. variant of Indonesia and Philippines suppresses tumor growth of hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.
Raissa R, Riawan W, Safitri A, Masruri M, Beltran M, Aulanniam A
F1000Res. 2023; 11:477.
PMID: 37829248
PMC: 10565427.
DOI: 10.12688/f1000research.109557.1.
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
Gunes A, Schmitt C, Bilodeau L, Huet C, Belblidia A, Baldwin C
Diabetes. 2023; 72(12):1820-1834.
PMID: 37757741
PMC: 10658070.
DOI: 10.2337/db23-0171.
Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2.
Xu Y, Zhu Y, Wu Z, Li S, Shao M, Tao Q
BMC Cancer. 2023; 23(1):906.
PMID: 37752418
PMC: 10521566.
DOI: 10.1186/s12885-023-11393-1.
Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism.
Lin W, Song H, Shen J, Wang J, Yang Y, Yang Y
Front Physiol. 2023; 14:1110926.
PMID: 37555019
PMC: 10405179.
DOI: 10.3389/fphys.2023.1110926.
Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production.
Zhu Y, Mei Y, Baby N, Teo H, Binte Hanafi Z, Salleh S
Commun Biol. 2023; 6(1):685.
PMID: 37400621
PMC: 10318068.
DOI: 10.1038/s42003-023-05036-1.
Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer.
Garbers C, Rose-John S
Methods Mol Biol. 2023; 2691:207-224.
PMID: 37355548
DOI: 10.1007/978-1-0716-3331-1_16.
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients.
Dalbeni A, Natola L, Garbin M, Zoncape M, Cattazzo F, Mantovani A
Cancers (Basel). 2023; 15(9).
PMID: 37173873
PMC: 10177287.
DOI: 10.3390/cancers15092406.
Targeting IL-6 trans-signalling: past, present and future prospects.
Rose-John S, Jenkins B, Garbers C, Moll J, Scheller J
Nat Rev Immunol. 2023; 23(10):666-681.
PMID: 37069261
PMC: 10108826.
DOI: 10.1038/s41577-023-00856-y.
Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar rats.
Alshehri F, Alorfi N
Front Pharmacol. 2023; 14:1130670.
PMID: 36825158
PMC: 9941161.
DOI: 10.3389/fphar.2023.1130670.